Eight Chinese medical workers who treated Ebola patients have been quarantined in Sierra Leone, as health experts grapple with ethical questions over the use of experimental drugs to combat the killer virus.
A Spanish missionary priest is the third Westerner with Ebola to be treated with an experimental drug that's never been tested in people and is said to be in very limited supply.
(HealthDay)—As the number of dead in the West African Ebola outbreak nears 1,000, many people are calling for the wider production and release of untested medicines that might help patients.
As the world scrambles to stem the rapid spread of the killer Ebola virus, the World Health Organization hosted a meeting on Monday to discuss the ethics of using experimental drugs.
Spain has imported a U.S.-made experimental Ebola drug to treat a Spanish missionary priest evacuated from Liberia last week after testing positive for the killer virus.
Federal health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use against an unprecedented outbreak of the deadly virus in West Africa.
A fast-spreading Ebola epidemic sparked states of emergency in overwhelmed west African nations Thursday as the death toll neared 1,000 and an elderly Spanish missionary was evacuated for treatment at home.
The decision to use an experimental drug to treat two Americans infected with Ebola, while nearly 1,000 Africans have already died from the deadly epidemic, has sparked controversy—but US experts say it was ethically justified.
The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts ...
The World Health Organization said on Wednesday it was convening an ethics meeting next week to explore the use of experimental treatment in the Ebola outbreak in West Africa.
An experimental drug given to two American patients with Ebola is made from tobacco leaves and is hard to produce on a large scale, a leading US doctor said Tuesday.
In one of the most ambitious attempts yet to thwart Alzheimer's disease, a major study got underway Monday to see if an experimental drug can protect healthy seniors whose brains harbor silent signs that ...
Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers at the Society of Nuclear ...
New drugs are making a dent against some hard-to-treat cancers, but some results raise fresh questions about whether the benefit is worth the cost.
(Medical Xpress)—Northwestern Medicine scientists have newly identified a protein's key role in cell and physiological aging and have developed – in collaboration with Tohoku University in Japan—an experimental ...